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CEO FOREWORD
The Australian Criminal Intelligence Commission has a national responsibility to provide 
information and intelligence on criminal activity. Much of the harm that Australians suffer 
at the hands of organised crime is due to the trade in illicit substances and abuse of licit 
substances at the instigation of serious and organised crime groups who profit from 
importing, trafficking, manufacturing and selling drugs.
This National Wastewater Drug Monitoring Program report is the fourth in a series of nine 
public reports which will detail the findings of the national wastewater program until the end 
of 2019. This report provides statistically valid datasets of drug use and distribution patterns 
across a large number of sites in capital cities and regional areas. 
Wastewater analysis is widely applied internationally as a tool to measure and interpret 
drug use within national populations, with the current national program in Australia 
representing world best practice. Wastewater analysis provides a measure of one important 
aspect of national health—the demand for a range of licit and illicit drugs. An understanding 
of this behaviour allows governments to effectively direct resources to priority areas, and 
also to monitor the progress of demand and supply reduction strategies.
EVOLUTION OF THE PROGRAM
This report includes wastewater data from all states and territories, enabling the National 
Wastewater Drug Monitoring Program to provide a national picture of drug use. In 
December 2017, 45 wastewater sites were monitored nationally. Based on 2016 Census 
data, these sites cover approximately 54 per cent of the Australian population—around  
12.7 million people. This report contributes further data to permit the identification of 
changes in usage patterns over the 17-month period from August 2016 to December 2017 and 
to build a comprehensive and increasingly detailed picture of national drug consumption. 
The content of this report involves a natural evolution of the existing National Wastewater 
Drug Monitoring Program. Changes of note in this report include the adoption of more 
sophisticated population estimates of wastewater treatment catchments, derived using the 
latest Census data from the Australian Bureau of Statistics and geographical information 
system analysis of populations reported within wastewater treatment catchments. These 
refinements increase both the precision and accuracy of consumption estimates and have 
been applied to all data presented in this report. We are grateful to our partners at the 
University of Queensland and University of South Australia for their ongoing efforts to 
enhance and deliver a leading edge program.
TRENDS IDENTIFIED DURING THIS REPORTING PERIOD
Of the drugs measured, consistent with previous reports, alcohol and nicotine continue to 
be the most consumed drugs in Australia. Methylamphetamine remains the most consumed 
illicit drug, with average consumption increasing since August 2017. 
2Consumption of other drugs measured by the program remains considerably lower. 
Although the previous report indicated a decrease in average cocaine consumption 
between April and August 2017, recent data indicate a noticeable increase in consumption. 
The consumption of MDA and MDMA remains low and variable across sites. In general, 
heroin consumption was lower than fentanyl and oxycodone consumption in most states 
and territories, with average regional consumption of fentanyl and oxycodone exceeding 
that in capital city sites. Mephedrone and methylone consumption remain low, at or below 
detection levels.
ADDITIONAL INSIGHTS GAINED FROM WASTEWATER ANALYSIS
Wastewater analysis provides a measure of the demand for a range of licit and illicit drugs. 
Analysis of wastewater data offers opportunities to address emerging problems, identify 
previously unknown drug threats and consumption patterns, and assists to measure the 
effectiveness of harm reduction initiatives and supply disruption strategies.
On comparing drug seizure data published in the Australian Federal Police Annual Report 
2016–17 and annual national drug consumption estimates derived from wastewater 
analysis for methylamphetamine, MDMA, cocaine and heroin, it is evident demand for 
harmful drugs remains robust. Based on the reported weights seized by the Australian 
Federal Police in 2016–17 and consumption estimates from the National Wastewater Drug 
Monitoring Program:
  the weight of heroin seized equated to around a quarter of the total estimated weight 
of heroin required to meet national demand
  the weight of methylamphetamine seized equated to over 40 per cent of the total 
estimated weight of methylamphetamine needed to meet national demand
  the weight of MDMA seized equalled the total estimated weight of MDMA needed to 
meet national demand
  the weight of cocaine seized exceeded the total estimated weight of cocaine needed to 
meet national demand.
The above examples highlight the resilience of drug markets and the enduring demand 
for drugs in Australia. They again reinforce that no single strategy in isolation can achieve 
sustained impacts and the ongoing necessity to employ a shared approach that targets 
supply, demand and harm reduction. 
I would like to thank the Australian Government for contributing the funding which made 
this initiative possible, and to acknowledge the Australian Criminal Intelligence Commission 
officers who contributed to the project. I am grateful for the valuable support and specialist 
expertise of the University of Queensland and the University of South Australia, who 
undertook the data collection and analysis which underpins this report. 
Michael Phelan APM 
Chief Executive Officer 
Australian Criminal Intelligence Commission
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The December 2017  
collection covers  
54.3 per cent of Australia’s 
population—about 12.7 million 
Australians. 
Use of new, sophisticated geospatial analysis 
methods incorporating water treatment 
catchment maps and 2016 Australian Census 
mesh blocks gives more accurate and precise 
consumption estimates.
Alcohol and nicotine remain the highest consumed 
substances and methylamphetamine continues to 
be the most consumed illicit drug tested.54%
Regional nicotine, methylamphetamine, MDA, 
oxycodone and fentanyl average consumption 
exceeded capital city consumption.
Capital city cocaine 
and heroin average 
consumption 
exceeded regional 
consumption.
SNAPSHOT
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Around a quarter of the 
heroin needed to meet 
national demand
Over 40 per cent of the 
methylamphetamine needed 
to meet national demand
The total weight of MDMA 
needed to meet national 
demand
In excess of the total weight 
needed to meet national 
demand for cocaine
Based on wastewater consumption estimates, in 2016–17 Australian Federal Police seized: 
Estimated annual consumption of 
methylamphetamine, cocaine, MDMA and 
heroin derived from wastewater data shows 
Australia is a stimulant nation.
8,387 kg 3,075 kg 1,280 kg 765 kg
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INTRODUCTION
This is the fourth in a series of nine National Wastewater Drug Monitoring Program reports 
to be publicly released by the Australian Criminal Intelligence Commission. The program 
aims to deliver on the recommendations of the Final Report of the National Ice Taskforce.  
It is the first program to provide leading-edge, coordinated national research and 
intelligence on illicit and licit drugs, with a specific focus on methylamphetamine and  
11 other substances.
In 2016, the Australian Criminal Intelligence Commission received $3.6 million in funding 
under the Commonwealth Proceeds of Crime Act 2002 to deliver the National Wastewater 
Drug Monitoring Program over three years. The program provides a measure, rather than 
an estimate, of the use of a number of illicit drugs, as well as licit drugs including nicotine, 
alcohol and some pharmaceuticals. It gives us valuable insight into the trends and emerging 
issues of drug consumption across Australia and can identify new sources of threat. 
The findings presented in the nine reports will give law enforcement, policy, regulatory and 
health agencies additional and more objective data on the use of methylamphetamine and 
other drugs. This data creates opportunities to shape the response to both the demand and 
the supply side of the illicit drug market, particularly in high-use areas.
IMPLEMENTATION
The Australian Criminal Intelligence Commission has contracted the University of 
Queensland, and through it the University of South Australia, to deliver the program. 
Relationships have been built between the universities and the operators of wastewater 
facilities across Australia to permit the collection and analysis of samples.
In this report, wastewater analysis from the National Wastewater Drug Monitoring Program 
measured the presence1 of the following substances:
  methylamphetamine
  amphetamine
  cocaine
  3,4-methylenedioxymethylamphetamine (MDMA)
  3,4-methylenedioxyamphetamine (MDA)
  heroin
  mephedrone
  methylone
  oxycodone
  fentanyl
  nicotine
  alcohol.
1 The contract recognises that threshold levels are substance dependent and will vary accordingly. Refer to the research 
findings for further information on detection levels, and whether it was possible to measure all substances.
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The first five substances are widely recognised illicit stimulants. Heroin is an illicit 
depressant. The next two substances, mephedrone and methylone, are illicit synthetic 
stimulants and are described as new psychoactive substances (NPS).2 Oxycodone and 
fentanyl are opioid pharmaceuticals with therapeutic application, but are also diverted to 
the illicit market. Nicotine and alcohol are licit drugs. The Australian Criminal Intelligence 
Commission will continue to review the appropriateness of the monitored substances with 
its partners, stakeholders and the universities. 
Both contracted universities will monitor wastewater at approximately 50 sites across 
Australia until the end of 2019. It is the intention of the program that capital city sites 
cover all state and territory capital cities, with the remaining sites covering regional cities 
and towns. Capital city sites will be monitored for the duration of the program, while the 
remaining sites will be reassessed periodically. Sites were selected to permit the Australian 
Criminal Intelligence Commission to provide data on major population areas, sites of actual 
or potential concern from a drug use perspective, and sites where the local authorities 
have established relationships with the two universities. In December 2017, 45 wastewater 
treatment plants participated nationally.
The breakdown of sites by jurisdiction for December 2017 is as follows:
2 Two other NPS, JWH-018 and JWH-073, which are synthetic cannabinoids are no longer monitored by the National 
Wastewater Drug Monitoring Program as they have not been detected in sites across Australia since monitoring 
commenced in August 2016.
1
5
6
1
9
6
9
8
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The Australian Criminal Intelligence Commission will continue engaging with all states 
and territories in an attempt to secure their ongoing participation in sampling for future 
reports. Participation from all states and territories is vital to informing our understanding 
of the national picture of drug use and demand. In the event that one or more states and 
territories decide not to participate in the national program in the future, the Australian 
Criminal Intelligence Commission will identify replacement sites from participating states 
and territories to ensure that the largest possible segment of the national population is 
sampled. Accordingly, the location of sites within and between states and territories may 
change over the three years of the contract. 
REPORTING
National Wastewater Drug Monitoring Program reports will be published as comprehensive 
public reports three times a year, in line with the program contract. In accordance with 
current wastewater analysis conventions, the terms of the contract, and to protect the 
integrity of the program, the exact locations of wastewater treatment plants will not be 
publicly released by the Australian Criminal Intelligence Commission. 
To maintain the confidentiality of the participating sites, each site was allocated a unique 
code so that results could be de-identified. However, trends in particular states and 
territories are still able to be identified. The public reports will incorporate a discussion 
of trends in drug use where distinct trends are seen—for example, between regional 
areas and capital cities, or between states and territories and nationally—and will include 
comparisons with testing from previous years where that data is available.
In order to inform appropriate responses, stakeholders in law enforcement, health and 
other relevant policy agencies may be provided with classified information identifying actual 
sampling locations. 
EXPLOITATION OF THE NATIONAL WASTEWATER DRUG MONITORING 
PROGRAM DATA 
The Australian Criminal Intelligence Commission intends that the findings of the National 
Wastewater Drug Monitoring Program analysis will be fundamental to the development 
of government policy and decision making, as the reports will provide a regular, timely, 
unambiguous and detailed measure of the level of demand for the listed commodities 
in the Australian population, complementing other drug datasets published in Australia. 
The fourth National Wastewater Drug Monitoring Program report measures drug use by 
approximately 54 per cent of the Australian population.3 It is hoped that wastewater data 
will be used with other available data sources to obtain a more comprehensive and accurate 
understanding of drug markets nationally and in the respective states and territories. 
3 The December 2017 population estimate is based on the Australian Bureau of Statistics 2016 Census data and catchment 
data supplied by the operators of the wastewater facilities and service providers.
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The Australian Criminal Intelligence Commission continues to engage with academic 
institutions, industry and public sector agencies concerning potential uses for data generated 
by the National Wastewater Drug Monitoring Program. Discussions have centred upon 
focusing responses in particular high-risk areas, measuring drug use in particular local areas, 
estimating the size of specific illicit markets, comparing wastewater data with other drug-
related data and exploring options for monitoring the effectiveness of existing demand, supply 
and harm reduction initiatives. The advantage the National Wastewater Drug Monitoring 
Program offers in all these contexts is that the data is collected on an ongoing basis, is 
reported regularly and can be shaped to accommodate changing circumstances. 
Making the National Wastewater Drug Monitoring Program data available to the public and 
to public agencies enriches understanding and informs the national conversation on drug 
trends and related demand. Because the collection and analysis protocols are similar, it is also 
possible to compare domestic drug consumption with international drug consumption,4 which 
may stimulate further discussions on alternative responses to the threat posed by drug use. 
Wastewater has been identified as offering an important, unified and consistent guiding 
tool in developing holistic drug responses. The National Wastewater Drug Monitoring 
Program is based on a well-established and internationally recognised methodology which 
has been applied to varying extents by many other nations. Australia is one of the few 
countries in the world where the program is funded by a national government, with the 
scope of sampling in Australia generating data which will help governments at both a state 
and national level to formulate appropriate responses. 
ESTIMATED NATIONAL CONSUMPTION
The Australian Criminal Intelligence Commission used wastewater data collected between 
August 2016 and August 2017 to estimate the annual weight of methylamphetamine, 
MDMA, cocaine and heroin consumed nationally (see Table 1). While the estimates are 
conservative, they provide valuable insight into Australia’s demand for illicit drugs that could 
not have been gained without the program. 
Table 1: Estimated annual national methylamphetamine, cocaine, MDMA and heroin 
consumption between August 2016 and August 2017.
Drug Estimated consumption 
kilograms per year
Methylamphetamine 8,387
Cocaine 3,075
MDMA 1,280
Heroin 765
 
4 International data from the Sewage analysis CORe group Europe (SCORE) was not available in time for it to be incorporated 
into this report. This information will be included in the fifth report, to be released in the third quarter of 2018.
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To put the size of the Australian methylamphetamine market into context, the total 
combined estimated weight of cocaine, MDMA and heroin consumed annually equates to 
around 60 per cent of the estimated weight of methylamphetamine consumed annually. 
This data also illustrates the variation in the size of these markets, with the estimated 
weight of methylamphetamine consumed annually being 6½ times that of MDMA and the 
estimated weight of cocaine consumed annually being four times that of heroin. 
In addition to providing insight into how the different drugs in the program compare, these 
consumption estimates also enable comparisons with seizure data. On comparing the 
estimated weight of methylamphetamine, cocaine, MDMA and heroin consumed annually 
with the weight of related drug seizures reported in the Australian Federal Police Annual 
Report 2016–17:
  The weight of heroin seized equated to around a quarter of the total estimated weight of 
heroin required to meet national demand.
  The weight of methylamphetamine seized equated to over 40 per cent of the total 
estimated weight of methylamphetamine needed to meet national demand.
  The weight of MDMA seized equalled the total estimated weight of MDMA needed to 
meet national demand.
  The weight of cocaine seized exceeded the total estimated weight of cocaine needed to 
meet national demand.  
From the above data it is evident that demand for these drugs remains robust and that a 
shared approach that targets supply, demand and harm reduction is critical to addressing 
drug use in Australia. Drug consumption estimates derived from wastewater data, when 
used in combination with other data such as seizure, arrest, price, purity and availability 
data, provide greater insight into the related markets and the potential impact of supply, 
demand and harm reduction strategies. 
EVOLUTION OF THE PROGRAM
The Australian Criminal Intelligence Commission will continue to work with the participating 
universities to enhance the program. Since its launch, the program has explored and 
implemented various enhancements that contribute to the delivery of better data and a better 
and more granular understanding of drug consumption in Australia. These enhancements 
include the ability to compare Australia’s drug consumption with measured consumption in 
different countries, and the inclusion of additional substances in the monitoring program as 
new methodologies are developed and endorsed by the scientific community. Discussions also 
include whether it may be possible to use alternative metabolites of some substances to more 
precisely measure their consumption in the community.
The fourth National Wastewater Drug Monitoring Program report reflects a further evolution 
of the program. For the first time the program implemented a new, more sophisticated 
methodology to estimate populations captured by wastewater treatment plant catchments, 
with the population estimate of usual residents within each catchment being refined using 
catchment maps provided by wastewater treatment authorities and 2016 Australian Census 
mesh blocks. This methodology incorporates the latest Australian Census data and will result 
in more precise and accurate population estimates for the areas covered by the program. 
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Wastewater data is an important part of the suite of datasets available to increase our 
understanding of drug consumption, demand and supply in Australia. Existing and future 
work incorporating wastewater data will include a comparison of consumption data with 
drug seizures in Australia. The Australian Criminal Intelligence Commission is working to 
ensure the broadest possible range of stakeholders are engaged throughout the life of the 
program, consulting with stakeholders through existing drug forums and direct discussions 
with agencies. This includes working with industry to increase our understanding of drug 
markets in Australia.
RESULTS FROM THE FOURTH REPORT
This fourth report of the National Wastewater Drug Monitoring Program builds on national 
drug consumption data contained in the preceding three public reports identifying drug 
use patterns across states, territories and the nation. It provides data on capital city and 
regional drug use and, where possible, comparisons with previous levels of use in sites 
across Australia. This and future reports will contribute further data to identify trends, 
changes in patterns of use and emerging issues, building a comprehensive and increasingly 
detailed picture of national drug consumption. Benefits of longitudinal wastewater data 
include the identification of emerging trends and patterns of use. This is illustrated through 
the cocaine data, where the population-weighted averages for cocaine consumption have 
doubled in capital city sites since August 2016, with almost a three fold increase observed in 
regional sites.
Reported results reflect per capita use in all locations and, with the exception of MDA, are 
expressed in terms of both the number of doses and the weight or volume per capita of the 
respective substances, to facilitate comparison between substances.
11
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RESEARCH FINDINGS
Prepared by the University of Queensland (B Tscharke, R Mackie,  
J O’Brien, S Grant, J Mueller) and University of South Australia  
(M Ghetia, H Aghera, R Bade, C Gerber, J White).
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LIST OF ABBREVIATIONS
ABS Australian Bureau of Statistics
ACIC Australian Criminal Intelligence Commission
ACT Australian Capital Territory
GIS Geographic information system
LC-MS/MS Liquid chromatography tandem mass spectrometry
LOD Limit of detection
LOR Limit of reporting
MDA 3,4-methylenedioxyamphetamine
MDMA  3,4-methylenedioxymethylamphetamine
NPS New psychoactive substances
NSW New South Wales
NT Northern Territory
NWDMP National Wastewater Drug Monitoring Program
QLD  Queensland
SA  South Australia
SPE Solid phase extraction
TAS Tasmania
VIC Victoria
WA Western Australia
WWTP Wastewater treatment plant
TERMINOLOGY
Methylamphetamine is also commonly known as methamphetamine. In this report, 
consistent with the preferences of the Australian Criminal Intelligence Commission, 
‘methylamphetamine’ is used.
MDMA is commonly known as ecstasy.
Alcohol consumption in this report refers to ethanol consumption but the more general term 
‘alcohol’ is used throughout.
Nicotine consumption has replaced tobacco consumption in this report as the target metabolites 
may also be derived from nicotine replacement products, such as gums and patches.
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1: EXECUTIVE SUMMARY
Wastewater analysis is now a standard method for measuring population-scale use of a 
range of different chemical compounds. The underlying concepts involved in wastewater 
analysis were demonstrated in the first national Australian report released in March 
2017. Estimates of drug usage in a population were back calculated from measured 
concentrations of drug metabolites (excreted into the sewer system after consumption) in 
wastewater samples. Spatial and temporal trends in drug use have now been included using 
this approach for several sites across Australia. The National Wastewater Drug Monitoring 
Program (NWDMP) of the Australian Criminal Intelligence Commission (ACIC) monitors 
selected substances of concern in most populated regions of Australia. The study now 
focuses on twelve licit and illicit drugs, including nicotine, alcohol, methylamphetamine, 
cocaine, MDMA (ecstasy) and heroin. Trends in estimated drug consumption will be 
established over the three-year project. Wastewater treatment plants (WWTPs) located 
across capital cities and regional Australia, covering all states and territories, have been 
invited to participate in this program. Previous reports used population estimates provided 
by the wastewater treatment authorities. For the first time the estimate of the usual 
residents within each catchment has been refined. Catchment maps provided by the 
wastewater treatment authorities were layered on the smallest available units of Census 
population counts (mesh blocks) in geographic information systems (GIS) software to yield 
the highest resolution population estimate available for the catchments based on Census 
data. The resulting overlapping usual resident population within each catchment was 
calculated and has been applied to all data presented in this report, which increases both 
the precision and accuracy of the consumption estimates. 
For this fourth report, wastewater samples were collected during weeks of October and 
December 2017. A total of 20 WWTPs in capital cities and a further 25 regional sites 
participated in the project for the December 2017 period, covering a population of more 
than 12 million Australians. Data from this report equates to coverage of approximately  
48 per cent and 54 per cent of Australia’s population for October and December, 
respectively. A total of 1,839 individual daily samples have been assessed since the 
beginning of the program, with new results from 414 additional samples added in this 
report. The collected samples provide relatively comprehensive, Australia-wide baseline 
data against which subsequent data can continue to be compared to ascertain both spatial 
and temporal trends. Twenty-four-hour composite wastewater samples were collected 
using time-proportional or flow-proportional autosamplers at the influent of each WWTP 
by plant operators. Samples were collected for up to seven consecutive days. Concentrations 
of drug metabolites were determined in the wastewater using liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) analytical methods. Drug consumption estimates for each 
catchment population were calculated from these measured concentrations using flow 
volumes and estimates of the catchment population size by Census data vs. catchment maps 
evaluation, together with excretion and dose data derived from the scientific literature.  
To maintain treatment plant confidentiality, each site was allocated a unique code and site 
names are not included in this report.
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The estimated drug usage across the 45 sites (December 2017) was consistent with previous 
reports. After normalising the amount of drug measured in wastewater for population size and 
average dose consumed, alcohol and nicotine were consistently the highest consumed drugs 
in all states and territories. Estimated consumption of nicotine was generally higher in regional 
areas compared to capital cities. In the case of alcohol, the difference was less pronounced. 
The Northern Territory had the highest consumption of nicotine and alcohol, but with only one 
participating site, the result may not be representative of the Territory as a whole. In other 
parts of Australia, alcohol consumption was similar for the most part, except for regional South 
Australia, where it was relatively low. This may be a consequence of samples being provided 
for weekdays only, when consumption is typically lower. Nicotine use across the nation was 
fairly consistent. 
Methylamphetamine remains the highest of the illicit drugs included in the report, in both capital 
cities and regional sites, and shows no tendency to decline. The highest methylamphetamine 
levels were seen in South Australia (capital city) and Western Australia (regional). 
Amphetamine is a metabolite of methylamphetamine and measured amphetamine 
concentrations across the sites were consistent, with the observed levels being primarily 
related to methylamphetamine metabolism rather than sourced from direct consumption. 
Compared to methylamphetamine, estimated usage of other stimulants was generally 
much lower, although no consistent pattern (profile) of usage for these other drugs could be 
observed between states and territories. Cocaine consumption in Australia is mostly centred 
in New South Wales across several capital city and regional sites. Levels in Queensland and 
the Australian Capital Territory have both increased to become nearly second highest in the 
nation. In comparison, usage was low at sites elsewhere around the country. MDMA usage 
was similarly low across most sites with a few site-specific exceptions. 
Oxycodone and fentanyl, which are both prescription pharmaceutical substances with abuse 
potential, had elevated consumption levels at several regional sites. Regional areas had 
average oxycodone use well above capital city sites in many states. Consumption of heroin 
varied widely, with minimal amounts detected in the Northern Territory and high levels 
recorded in sites in Victoria and the Australian Capital Territory, as well as a few individual sites 
in other states.
After removing the proportion of MDA attributable from MDMA metabolism, use of the drug 
appeared variable across the nation, with South Australia being the lowest. A feature was a 
site in regional Queensland where measured levels were extremely high. For the other drugs 
included in this study, methylone and mephedrone concentrations were generally at or below 
detection levels at all participating sites. 
The collection of wastewater samples at regular intervals allowed for the temporal comparison 
of consumption data. While small overall changes were evident at both a site and a state or 
territory level, more data are required to draw longer term conclusions. The recent declines in 
methylamphetamine use in Queensland and Western Australia, and to a lesser extent South 
Australia, were clear reversals in longer term trends. A gradual reduction in pharmaceutical 
opioid use, particularly oxycodone, was also apparent.
16
Australian Criminal Intelligence Commission 
National Wastewater Drug Monitoring Program—Report 4, March 2018
2: INTRODUCTION
2.1. PREAMBLE
Wastewater analysis is a technique for delivering population-scale consumption of 
substances. The University of Queensland and University of South Australia have been 
commissioned to provide drug consumption data to the ACIC for a period of three years, 
beginning in August 2016. Wastewater treatment sites are assessed bimonthly in the case 
of capital city sites and every four months for regional sites. The aim is to acquire data on 
the population-scale use of substances that cause potential harm, either through addiction, 
health risks, or criminal and antisocial behaviour. The intention is to establish baseline 
data of substance use across Australia. This fourth National Wastewater Drug Monitoring 
Program report compares consumption data from the first three reports with results 
obtained subsequently from October and December 2017. 
Compounds of concern include nicotine (cigarettes, gum, patches, e-cigarettes, etc), 
ethanol from alcohol intake, pharmaceutical opioids with abuse potential, illicit substances 
such as methylamphetamine, MDMA, cocaine and heroin, as well as a number of new 
psychoactive substances (NPS). The compounds amphetamine and MDA were measured 
but not included in the initial reports. Amphetamine is a by-product of methylamphetamine 
pyrolysis and also one of its metabolites and we found the levels to correspond fully to the 
excretion of methylamphetamine. MDA is a metabolite of MDMA, but since the proportion 
of MDA derived from MDMA is known, the difference between measured MDA and 
MDMA metabolite has now been included in the current report. The amount of MDA was 
calculated by subtracting 1.65 mg of MDA for every 100 mg of MDMA consumed (Pizarro 
et al. 2002; Khan & Nicell 2011). The report presents patterns of substance use across 
Australia, showing differences in levels between capital cities and regional centres, within 
states and territories, and nationally. 
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3: METHODS
The method underlying wastewater based monitoring of drug use in a given population is 
based on the principle that any given compound that is consumed (irrespective of whether 
it is swallowed, inhaled/smoked or injected) will subsequently be excreted (either in the 
chemical form it is consumed and/or in a chemically modified form that is referred to as 
a metabolite). The excreted compound or metabolite will eventually arrive in the sewer 
system. The drugs and their metabolites of interest in this study are given in the first National 
Wastewater Drug Monitoring Program report (available at www.acic.gov.au), as well as an  
in-depth description of the methodologies involved.1 Collectively, waste products in the 
sewer system arrive at a WWTP where wastewater samples are collected over a defined 
sampling period. Measuring the amount of target compound in the wastewater stream 
allows for a back calculation factor to be applied to determine the amount of drug that was 
used over the collection period (Figure 1). The method is non-invasive and is done on a 
population-scale level, so individuals are not targeted and privacy is respected.
Figure 1: Schematic of the population catchment area and methodology employed to 
convert measured concentration of substances in wastewater to mass loads or doses 
consumed per day per normalised population. 
To obtain an estimate of drug use, representative samples are collected over a given period 
(typically 24 hours) using autosamplers that collect time or flow proportional samples. 
Wastewater treatment plant operators provide assistance with collecting the samples from 
the influent autosampler (where the wastewater enters the treatment plants). Details of the 
calculation methods are given in the first National Wastewater Drug Monitoring Program report. 
1 Information in relation to heroin appears in Report 3.
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of wastewater flowing into WWTP 
over 24 hours
Divide by catchment 
population 
(thousands of people)
DOSES OF DRUG CONSUMED/1000 PEOPLE
(calculated)
(number of doses of drug consumed on average by 1000 people 
in the catchment in 24 hours)
Divide by excretion rate i.e. 
the mass of metabolite 
excreted for every unit of drug 
consumed, and multiply by the 
difference in molecular weight 
between the drug and its’ 
metabolite
Divide by the mass of 
drug typically 
consumed in one go 
(i.e. the standard dose)
18
Australian Criminal Intelligence Commission 
National Wastewater Drug Monitoring Program—Report 4, March 2018
Collected wastewater samples were analysed at the University of South Australia and the 
University of Queensland laboratories. The steps routinely performed in our laboratories 
are based on filtration of the samples followed by an enrichment/concentration step where 
the concentrated sample is injected, or (for chemicals with sufficiently high concentrations) 
direct injection of samples into the analytical instruments. The instrumental analysis 
consists of chromatographic separation and subsequent compound specific detection.  
A summary of the extraction and analytical methods is given in the first National 
Wastewater Drug Monitoring Program report. An updated excretion and dose table 
including the heroin metabolite, 6-monoacetylmorphine, is found in Appendix 1.
3.1. PARTICIPATING WASTEWATER TREATMENT PLANTS (WWTPS)
Forty-five WWTPs across Australia participated in this study for the December 2017 
collection (Figure 2). Of these, 20 sites were located in capital cities and a further 25 were 
regional sites covering a wide range of catchment population sizes. Sites were selected 
by the ACIC. The number of participating sites for October and December 2017 are listed 
in Table 2 and Appendix 2. A complete list of participating sites, number of samples 
and relative catchment sizes are listed in Appendix 3. To maintain the confidentiality of 
participating sites, all sites were allocated a unique code to de-identify their results. Only 
site codes are presented in the results sections.
Figure 2: Participating WWTPs in December 2017, showing the split between capital 
city and regional plants by state and territory. The colours in this figure are used in the 
remainder of the report to identify results relating to individual states and territories.
3C
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5R
3C
6R
3C
5R 1C
2C
4R
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R = Regional WWTP
Participating WWTPs per State/Territory
1C
0R
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5R 1C
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4R
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Participating WWTPs per St te/Territory
1C
0R
3C
2R
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Table 2: Number of participating WWTPs for the periods covered in this report. Every 
second collection period aims to collect data from both regional (R) and capital city (C) 
sites (December), while the in-between collection periods (October) aim to collect data 
from capital city sites only.
Oct-17 Dec-17
State/territory C R C R
ACT 1 – 1 –
NSW 3 –  3 5
NT – – 1 –
QLD 3 –  3 6
SA 4 – 4 5
TAS 3 –  3 2
VIC 2 – 2 4
WA 3 –  3 3
Population (millions) C & R 11.2 – 11.2 1.5
Total Population (millions) 11.2 12.7
% of Australian population 47.9% 54.3%
3.2. SAMPLE COLLECTION AND PREPARATION
Composite samples were collected by treatment plant staff daily on seven consecutive days 
from Monday to Sunday, or where seven days was not feasible, across as many consecutive 
days as possible. Samples were stored at 4oC or were frozen prior to transport to Adelaide 
or Brisbane. Further details of the sampling protocol and relevant quality controls are 
included in Irvine et al. (2011), Lai et al. (2011), Lai et al. (2015), Tscharke et al. (2016). All 
other descriptions of calculations, extractions and analytical methods are outlined in the 
first National Wastewater Drug Monitoring report (available at www.acic.gov.au).
3.3. PRESENTATION OF DATA AND INTERPRETATION OF GRAPHS
Reported averages: All averages for state/territory or Australia-wide drug consumption data 
are presented throughout this report as population weighted averages. The number of people 
in the catchment population is used as the weighting for the respective drug consumption 
data for that population. For example, to calculate the population weighted average of capital 
city methylamphetamine consumption, the methylamphetamine consumption data for each 
WWTP was multiplied by the respective population number; all data were then summed 
and divided by the total population across all capital city sites. Reported average values are 
therefore not skewed towards usage data from small, non-representative populations.
Per capita consumption: The per capita consumption estimates presented in this report are 
calculated using the total estimated catchment population (which includes children). For 
example, per capita alcohol consumption has previously been reported by the Australian 
Bureau of Statistics (ABS) based on population numbers for people aged 15 and over. The 
consumption values presented in the current report will be under-estimated compared to 
those determined for an adult-only population. For consistency, data from other studies 
included in this report were recalculated where necessary using estimated total population. 
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Graphical presentation of data: An overview of how the data is presented in the graphs 
for the individual sites is given in Figure 3. This includes information on interpreting the 
consumption data presented on the vertical axes in all graphs in this report. In some graphs, 
the values plotted in the graph can be read as either mass of drug consumed (left axis) 
or doses of drug consumed (right axis). For the specific case of MDA, the amount of MDA 
excreted following MDA consumption is not known, and therefore for this drug we can only 
express the results as how much drug was excreted into the sewer network, e.g. the mg 
excreted per 1,000 people per day.
Figure 3: Explanation of the graphical representation of data for individual sites. General 
concepts relevant to all graphs in the report are also outlined (unique site codes, 
explanation of vertical axes, colour coding).2
2 For specific parameters and equations included in Figure 3 see Report 1.
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Instrumental method limits of detection and limits of reporting: Since the wastewater 
samples contain very low quantities of particular drugs, the limit of detection (LOD) was 
determined analytically as the lowest concentration of that drug that could be distinguished 
in the sample (using the methods described in Report 1). A drug may be present at a 
concentration below the LOD. However, trace quantities may actually be present at 
undetectable levels. The limit of reporting (LOR) is a concentration (higher than the LOD), 
above which we have high confidence that the concentration measured on the analytical 
instrument is accurate. Above the LOD but below the LOR there may be some uncertainty 
as to the actual concentration. To be conservative (a drug may be present but there is 
uncertainty as to its concentration) and in line with current practice, for back calculations 
to estimate per capita consumption, a concentration below the LOD is included at a value 
of LOD. A concentration above the LOD but below LOR is included at the midpoint between 
the LOD and LOR (i.e. (LOD + LOR)/2).
Weekly pattern of drug use: The pattern of drug use over the sampling week for the sites in 
this report cannot be elucidated from the data included in the current report. We present 
only maximum, minimum and average (for the individual sites) (Figure 3) and only average 
(or population weighted average, see above) values for all other graphs. Consistent patterns 
of drug use in Australia from previous wastewater-based epidemiology studies indicate 
that some illicit drugs such as cocaine, MDMA, mephedrone and methylone have high 
variation in weekly consumption rates, with higher consumption on weekends. Other drugs 
such as methylamphetamine, oxycodone and fentanyl appear to have lower daily variation 
suggesting that their consumption is consistent throughout the week (Lai et al. 2015, 
Tscharke et al. 2016). 
3.4. REFINING THE WASTEWATER CATCHMENT POPULATION ESTIMATE
In reports one to three, the estimate of the residential population living within the boundary 
of the wastewater catchments has been provided by the wastewater treatment authorities. 
These populations have been used to calculate the consumption of substances to units of 
mg/day/1,000 people or doses/day/1,000 people. These populations have been estimated in 
various ways, including the number of water connections, the number of municipal wheelie 
bins within the catchment, the total flow volume received at the treatment plant, plant 
capacity projections, or the organic nutrient loads within the wastewater. For the first time 
in this report, we have refined the population estimate using a new methodology, which will 
increase the accuracy of the population estimate. The catchment maps that were provided by 
wastewater treatment authorities were geo-referenced (input into GIS software) and merged 
with the 2016 ABS mesh blocks (the smallest unit of population published by the ABS, typically 
containing between 30 to 60 dwellings). 
An example of a hypothetical catchment, typical of this study, is shown in Figure 4. The 
population within the overlapping catchment and mesh block areas was summed to 
provide the population estimate for the catchment. In instances where the mesh block 
was not contained fully within the catchment boundary, the ratio of the population was 
estimated based on the proportion of area within the catchment (for instance, if 50 per 
cent of an individual mesh block area was within the catchment, then 50 per cent of the 
population of that mesh block was used in the estimate). Overall, an estimate of the possible 
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catchment population undercount or overcount using this estimation method was calculated 
and is included in Appendix 4. This is discussed further in Appendix 5, along with a diagram. On 
average, the total population overcount or undercount was very low at around four per cent, 
indicating a high precision of the refined population estimate method. The resulting population 
estimates for each catchment are the most accurate using the 2016 Australian Census and 
should well-reflect the average resident population. 
Figure 4: Example catchment boundary map (red line) and ABS mesh block data (black lines) 
layered on top of Google satellite imagery (background). Note: map does not depict a real 
wastewater catchment.
1 0 1 2 3 4 km
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4: RESULTS
Estimated drug consumption data are presented in several different ways in the following 
sections to allow comparisons of drug use at the individual site level (Section 4.1), between 
states and territories (Section 4.2) and within each state and territory (Section 4.3). 
We recommend exercising caution when comparing results between sites. A list of the 
detection frequency for each drug is found in Appendix 6. For this report we have refined 
the current population estimates for higher accuracy by integrating the specific wastewater 
catchment areas against the high-resolution population data recently released from 
the 2016 Census. The uncertainties in individual population estimates have less impact 
when data are averaged, for example when broader comparisons at the state/territory or 
international level are undertaken. The uncertainties in population numbers are particularly 
evident in smaller regional communities or sites where short-term population changes 
occur due to employment opportunities, tourism or festival events.
4.1. INDIVIDUAL SITE COMPARISON OF DRUG USE IN DECEMBER 2017
4.1.1 NICOTINE AND ALCOHOL
Tobacco consumption was estimated by measuring two nicotine metabolites. The method 
does not distinguish between nicotine intake from tobacco or electronic cigarettes and 
nicotine replacement therapies, such as patches and gums. Therefore, for the sake of 
accuracy, the estimate is reported as nicotine in this report. Estimated nicotine consumption 
varied significantly between sites and regions (Figure 5). Sites in regional areas across 
all states and territories showed noticeably higher per capita consumption levels during 
December 2017 than capital city precincts. This was evident from the regional vs. capital 
city averages for the December sampling period (red horizontal and dotted blue lines,  
Figure 5). South Australia was the only region where consumption in capital city sites 
matched rural levels. 
Alcohol was measured using a specific metabolite of ethanol. Differences between the 
average capital city and regional centre alcohol consumption were less pronounced than 
for nicotine (Figure 6). Many sites showed a wide range over the collection week. Alcohol 
consumption in some regional areas of Western Australia, South Australia and parts of 
Queensland were well below the national average. However, many regional sites did not 
sample on weekends, when consumption of alcohol is typically higher. The Northern 
Territory, capital sites of Tasmania and a couple of Western Australian sites were above the 
national capital city and regional averages.
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Figure 5: Estimated nicotine consumption for December 2017 in mass of nicotine 
consumed per day (left axis) and number of cigarettes per day (right axis) per thousand 
people. The number of collection days varied from 4–7. 
Figure 6: Estimated alcohol consumption for December 2017 in volume consumed per day 
(left axis) and standard drinks per day (right axis) per thousand people. The number of 
collection days varied from 4–7. 
4.1.2 STIMULANTS
The relative estimated consumption levels across the participating sites for four stimulants—
methylamphetamine, cocaine, MDMA and MDA—are described in more detail below.
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4.1.2.1 METHYLAMPHETAMINE
Estimated mass loads of methylamphetamine were high compared to other illicit substances. 
The average regional and capital city consumption were at similar levels. However, large site 
differences were evident. The high variability in consumption was observed across all states. 
Mass loads in capital city South Australia were the highest in the nation in December 2017 
(Figure 7), while a site in Victoria had the highest regional mass load. 
Figure 7: Estimated methylamphetamine consumption for December 2017 in mass 
consumed per day (left axis) and doses per day (right axis) per thousand people. The 
number of collection days varied from 4–7. 
4.1.2.2 AMPHETAMINE
The concentration of amphetamine observed in the August 2016 and December 2017 
samples strongly correlated with the methylamphetamine concentrations, with approximately 
seven times higher methylamphetamine measured than amphetamine for both periods 
(see Appendix 4 of Report 1) which is consistent with the reported amphetamine excretion 
range following methylamphetamine consumption (Gracia-Lor et al. 2016). Therefore, we 
assumed that the levels of amphetamine measured were predominantly metabolites of 
methylamphetamine. It is possible that some of the amphetamine measured could be a result 
of amphetamine ingestion, but due to the much higher methylamphetamine consumption 
and excretion profile, this cannot be confirmed by our present data.
4.1.2.3 COCAINE
Cocaine was measured using its specific metabolite, benzoylecgonine. Unlike 
methylamphetamine, capital city areas on average had higher cocaine use than regional 
centres (Figure 8). However, it has to be recognised that many regional sites did not provide 
weekend samples, unlike capital cities, when consumption of cocaine is known to peak  
(Lai et al., 2016 and Tscharke et al., 2016). Western Australia had relatively low consumption 
in both regional and capital city areas. In contrast, capital city New South Wales showed the 
highest levels nationwide, while consumption in regional parts of the state was also higher 
than the national average. Nevertheless, the scale of cocaine use in Australia remained 
noticeably lower than methylamphetamine levels. 
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Figure 8: Estimated cocaine consumption for December 2017 in mass consumed per day 
per thousand people (left axis) and doses per day (right axis). The number of collection 
days varied from 4-7. 
4.1.2.4 MDMA (3,4-METHYLENEDIOXYMETHYLAMPHETAMINE)
In comparison with other illicit substances, estimated consumption of MDMA was low across 
the country (Figure 9). Site 10 in capital city Northern Territory had relatively high levels on 
some days of the week, but in general, levels were comparable across the nation. The regional 
average was slightly lower than capital city sites. A direct comparison of regional and capital 
city sites in some states (e.g. South Australia) may be inappropriate, as many regional sites did 
not sample on weekends when MDMA consumption is typically higher.
Figure 9: Estimated MDMA consumption for December 2017 in mass consumed per day 
(left axis) and doses per day (right axis) per thousand people. The number of collection 
days varied from 4–7. 
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4.1.2.5 MDA (3,4-METHYLENEDIOXYAMPHETAMINE)
MDA previously had low overall detection frequency using a direct injection method. In 
this latest report, the compound was detected after concentrating the sample using solid 
phase extraction (SPE) prior to analysis to improve the sensitivity of the method. Data is 
not available in the scientific literature for the proportion of MDA that is eliminated after 
MDA consumption. However, data is available detailing the proportion of MDA eliminated 
after MDMA consumption. Therefore, the proportion of MDA attributable from MDMA 
metabolism was subtracted from the total measured amount of MDA for each site. Data 
for MDA is expressed as mg excreted per 1,000 people per day and cannot be expressed as 
consumption due to the lack of metabolic information of MDA elimination following MDA 
consumption. Although the dosage of MDA is not known, it is likely to be similar to that of 
MDMA, of around 100 mg. The daily mass loads for regional sites were on average higher 
than capital cities (Figure 10). Site 12 in Queensland had very high levels compared to other 
sites in the state and elsewhere and may have distorted the average value for regional 
centres. Since the parent drug is measured in wastewater, disposal of unused drug into the 
sewer system may result in unusually high values being recorded. South Australia generally 
had the lowest levels of MDA, both in regional and capital city centres.
Figure 10: Estimated MDA consumption for December 2017 in mass consumed per day per 
thousand people. The number of collection days varied from 4-7. 
The arrow above the graph indicates the maximum of QLD Site 012. The axes remain at a smaller 
value to allow comparison between areas of lower MDA excretion.
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4.1.3 OPIOIDS
Two pharmaceutical opioids were measured, as well as heroin, an illicit drug.
4.1.3.1 PHARMACEUTICAL OPIOIDS
Although oxycodone and fentanyl are legally prescribed pharmaceuticals, they are substances 
with abuse potential. The metabolism and excretion of both compounds are well characterised. 
The major metabolite of each compound was measured to estimate drug consumption. 
Consumption of oxycodone in regional sites was well above capital city levels, with the regional 
national average being higher than that of the capital cities (Figure 11). Regional Queensland 
and parts of Tasmania and Victoria were amongst the highest overall users of oxycodone, while 
Tasmania was highest of the capital city sites and Victoria the highest of the regional sites. 
The extent of fentanyl use was very variable across the nation. Some regional centres in almost 
every state had values well above the national average (Figure 12). Two locations in particular, 
Site 81 and Site 16 in New South Wales, gave values that were almost 2–3 fold higher than the 
next highest measurement. Except for Tasmania, regional consumption was substantially higher 
than capital city areas. Rates of fentanyl use in capital cities across Australia were of comparable 
levels, with relatively small differences in per capita consumption per day between sites.
Figure 11: Estimated oxycodone consumption for December 2017 in mass consumed 
per day (left axis) and doses per day (right axis) per thousand people. The number of 
collection days varied from 4–7. Average AverageAverage
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Figure 12: Estimated fentanyl consumption for December 2017 in mass consumed per day 
(left axis) and doses per day (right axis) per thousand people. The number of collection 
days varied from 4–7. 
4.1.3.2 HEROIN
Heroin is metabolised by users and excreted in low amounts as the unique metabolite, 
6-monoacetylmorphine (6-MAM). A method to detect heroin by 6-monoacetylmorphine 
was described in a paper by Tscharke et al., 2016. Since 6-MAM is characteristic of heroin 
use, it can be used to distinguish heroin from other opioids such as morphine and codeine. 
Heroin consumption in Australia in December 2017 was relatively low (Figure 13). Some 
regional areas of Tasmania and New South Wales recorded the highest levels of all 
measured locations. South Australia remains lower nationally. 
Figure 13: Estimated heroin consumption for December 2017 in mass consumed per day 
(left axis) and doses per day (right axis) per thousand people. The number of collection 
days varied from 4–7. Average AverageAverage
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4.1.4 NEW PSYCHOACTIVE SUBSTANCES 
Methylone and mephedrone were included in the study. Limited information is available on 
the human metabolism and excretion of these drugs. Therefore, the parent compound was 
measured. It is probable that a significant proportion of the ingested drug is converted into 
different metabolites. Apart from sporadic instances of methylone detections in Queensland, 
only a few sites showed evidence of methylone and mephedrone use. The measured levels 
were mostly below the limits of reporting. Sites that showed the presence of the two 
compounds are qualitatively listed in Table 3 for the December 2017 period. The temporal 
changes in detections per state (number of samples above LOD) are shown in Figure 14.
Table 3. The number and code of sites per state and territory where mephedrone and 
methylone were detected in December 2017. The total number of daily samples that were 
assessed was 288. 
          Number of detections Dec 2017    Sites detected Dec 2017
State/territory Mephedrone Methylone Mephedrone Methylone
NT 0 3 010
ACT 0 1 009
NSW 18 31 006, 008, 068 003, 006, 008, 
016, 025, 068, 115
QLD 5 10 002, 012, 029 005, 012 
SA 0 4 063
TAS 0 3 018
VIC 0 13 001, 067, 061, 
114
WA 0 0
Total 23 65   
Figure 14: The percentage of all samples where mephedrone and methylone were detected.
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Figure 14 (continued): The percentage of all samples where mephedrone and methylone 
were detected.
4.2. STATE AND TERRITORY COMPARISON OF DRUG USE 
The total level of each drug outlined in the preceding reports per state or territory was 
compared with subsequent collection periods included in the current report. Every effort 
was made to assess the same sites for each period. However, as the individual sites and 
the number of sites used to generate the population-weighted averages may have changed 
between periods, comparing between time points should be done with caution. This 
would be most evident for the regional averages, which had more variation in participation 
between each period (see Appendix 3 for a comprehensive list of participating sites 
and number of days assessed per sampling campaign). Note: the lines on each graph 
representing averages are the cumulative average across all sampling time points.
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4.2.1 NICOTINE AND ALCOHOL
Average nicotine consumption in samples collected from regional sites was generally higher 
when compared to the capital cities (Figure 15). In some states and territories, nicotine 
consumption showed steady levels over the total collection periods. Western Australia 
showed an overall decrease for both capital city and regional areas. In the case of alcohol, 
the difference between overall capital city and regional centre consumption within each state 
or territory was less pronounced, except for South Australia, where regional use is almost 
half that of the capital city (Figure 16). For the most part, consumption levels remained 
steady with no apparent trend in terms of changes in use over time within each region.
Figure 15: Estimated average consumption of nicotine by state/territory, where 1 cigarette 
contains 1.25 mg of nicotine. 
 
 
Figure 16: Estimated average consumption of alcohol by state/territory. A standard drink 
is 10.0 g or 12.5 mL.
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4.2.2 ILLICIT DRUGS
The trend in methylamphetamine use was variable in many parts of the country (Figure 17). 
Consumption in the Australian Capital Territory, New South Wales, Tasmanian and Victoria 
remains stable, while Queensland is increasing, particularly in city sites. South Australia had the 
highest capital city consumption, but no clear trend was apparent. Western Australia had the 
highest regional levels of methylamphetamine consumption. 
When plotted against historical levels recorded in the three regions, the previously described 
decline or levelling off in methylamphetamine consumption in South Australia was largely 
maintained, while Western Australia is increasing. Levels in Victoria showed a decline (Site 67) 
or remained steady (Site 1) over the current and historical periods (Figure 18). It is not yet clear 
whether these are part of longer term trends. 
Figure 17: Estimated average consumption of methylamphetamine by state/territory.
Figure 18: Change in methylamphetamine consumption for sites with historical data. 
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Figure 18 (continued): Change in methylamphetamine consumption for sites with historical data. 
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The consumption of cocaine in capital city sites in New South Wales remained high for the 
duration of the monitoring period compared to other Australian regions (Figure 19). The 
upward trend in consumption observed in the previous report for the Australian Capital 
Territory continued after April 2017. Small increases were evident in other states, but these are 
from a very low base. Regional consumption was noticeably lower than in capital cities in every 
state and territory, except Queensland. Western Australia and Tasmania remained well below 
the national average. 
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Figure 18 (continued): Change in methylamphetamine consumption for sites with 
historical data. 
Figure 19: Estimated average consumption of cocaine by state/territory.
MDMA use in Australia appeared to be on the decline in all states and territories, except the 
South Australian capital city region (Figure 20). Use in the Northern Territory remained high 
compared to other parts of the country, but the August 2017 figure was well down on the 
initial value recorded a year ago. Regional centres showed levels slightly below the capital city 
locations. However, this may be attributable to some regional sites not providing weekend 
samples, when consumption is typically higher. The actual trend would not be affected by 
sampling day and is a reasonable measure of changes in consumption over the study period.
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Figure 20: Estimated average consumption of MDMA by state/territory.
Figure 21: Estimated average consumption of MDA by state/territory.
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  Large variations amplified by 
relatively low consumption
  Declining rates of use in many areas
MDA use, corrected for the proportion derived from MDMA (Khan & Nicell 2011), showed 
that regional Queensland had the highest levels, while most other states and territories 
were very similar (Figure 21). South Australia and capital city New South Wales were at 
levels below average. The regional and overall national averages were skewed somewhat by 
the high MDA levels detected at Site 012 in Queensland.
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4.2.3 OPIOIDS
The average levels of oxycodone and fentanyl use were higher in regional areas of a number 
of states (Figure 22 and Figure 23). Since the first report in March 2017, which contained 
analysis of samples collected in August 2016, consumption of the pharmaceutical opioids 
declined in some regions; for example, regional New South Wales, South Australia and 
Western Australia. Capital cities of the Australian Capital Territory and Tasmania showed an 
increase in consumption, particularly for oxycodone. Some fluctuations in use were evident 
for the most part in other states and territories. The variation in participating rural sites 
(and hence the sampled populations) may also have an effect on the observed trend of the 
population-weighted averages. 
Figure 22: Estimated average consumption of oxycodone by state/territory.
Figure 23: Estimated average consumption of fentanyl by state/territory. 
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  Consistently higher regional use in many 
states and territories
  Small overall annual changes in capital cities
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  High regional use showing declining trends
  Capital city consumption trending 
downwards except in the ACT and TAS
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While heroin was included for the second time and historical data are lacking for most sites, 
a state and territory comparison of the use of the substance showed that consumption was 
highest in Victoria (Figure 24). In general, regional areas of each state had lower levels of 
heroin use, with New South Wales the only exception. The extent of heroin consumption has 
been measured in capital city South Australia since 2013. Together with the current reporting 
period, levels of heroin consumption for the region have been slightly declining (Figure 25).
Figure 24: Estimated average consumption of heroin by state/territory. 
Figure 25: Change in heroin consumption in South Australia. 
4.2.4 NEW PSYCHOACTIVE SUBSTANCES (NPS)
Methylone and mephedrone were only detected sporadically and at very low levels 
compared to other substances included in the report (December mephedrone and 
methylone results are shown in Table 3). 
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4.2.5 CAPITAL CITY AVERAGES
For the purposes of determining representative population trends for the collective 
catchments included in the report over the total sampling period, the averaged capital city 
site populations were expressed as the total capital average consumption of illicit stimulants 
(Figure 26). A complication with this type of analysis was that fewer sites were sampled 
between August 2016 and December 2017, so the contributing population was smaller 
between these dates. Some approximations had to be made to account for the absence of 
some densely populated regions (e.g. October 2016 for capital city New South Wales and 
Queensland). For the total population included in the report, methylamphetamine appeared 
to show a steady decline from October 2016 to June 2017, with an increase from August 
2017. With additional data from future collections, the significance of any trend will become 
more apparent. MDMA levels declined overall over the year on year reporting period, but 
since detected levels are very low, the result may not be significant. Cocaine consumption 
has shown an overall increase since August 2016. In terms of legal substances with abuse 
potential, nicotine consumption remained largely unchanged over the reporting period  
(Figure 27). In contrast, the two pharmaceutical opioids included in the study showed an 
overall decline in capital city areas since August 2016. In regional areas, fentanyl remained 
steady for the year on year period, but showed a decline from August 2016 to April 2017.  
In the case of alcohol, marginal changes were evident.
Figure 26: The population-weighted average of all sites for methylamphetamine, MDMA 
and cocaine. 
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As Queensland and New South Wales capital city sites were not sampled in October 2016, their 
average consumption in August and December 2016 was used to provide the overall October 
estimate. Regional areas were only sampled every second collection period. 
Figure 27: The population-weighted average of all sites for nicotine, alcohol, oxycodone, 
fentanyl and heroin. 
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Figure 26 (continued): The population-weighted average of all sites for methylamphetamine, 
MDMA and cocaine. 
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Figure 27 (continued): The population-weighted average of all sites for nicotine, alcohol, 
oxycodone, fentanyl and heroin. 
As Queensland and New South Wales capital city sites were not sampled in October 2016, their 
average consumption in August and December 2016 was used to provide the overall October 
estimate. Regional areas were only sampled every second collection period.
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4.3. DRUG PROFILE FOR EACH STATE AND TERRITORY
In order to compare the scale of use of different types of drugs within the same region  
(for example, within a state or territory), drug consumption was reported as the number of 
doses consumed. When the amount of drug measured in wastewater was normalised for 
population size and average dose consumed (conversion factors listed in the first National 
Wastewater Drug Monitoring Program report and in Appendix 1), alcohol and nicotine 
remained consistently the highest consumed drugs in all states and territories.  
For example, the national average consumption of nicotine and alcohol per 1,000 people 
per day were 1,480 cigarettes per 1,000 people (Figure 5) and 1,370 standard drinks per day 
per 1,000 (Figure 6), whereas for methylamphetamine, the national average consumption 
was closer to 40 doses per 1,000 people per day (Figure 7). 
In agreement with previous reports, methylamphetamine consumption remained the 
highest amongst the measured illicit drugs and opioids in this report, across all regions of 
Australia (Figure 28 and Figure 29). This trend was consistent for both capital cities and 
regional sites. Based on the consumption profiles of other drugs detected in this study 
(cocaine, MDMA, oxycodone and fentanyl), no other consistent patterns of usage within 
the different states and territories were observed. Oxycodone and fentanyl use were 
very similar within almost all states and territories, with small differences between the 
proportions in capital cities vs. regional areas.
Figure 28: Profile of average drug consumption by state or territory, for ACT, NSW, NT and 
QLD. Consumption is shown as the number of doses per 1,000 people per day to allow 
comparison of drugs of different types within the same region (state or territory).
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Figure 28 (continued): Profile of average drug consumption by state or territory, for ACT, 
NSW, NT and QLD. 
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Figure 29: Profile of average drug consumption by state or territory, for SA, TAS, VIC and 
WA. Consumption is shown as the number of doses per 1,000 people per day to allow 
comparison of drugs of different types within the same region (state or territory). 
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Figure 29 (continued): Profile of average drug consumption by state or territory, for SA, 
TAS, VIC and WA.
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7: APPENDICES
APPENDIX 1: DRUG-SPECIFIC PARAMETERS FOR ANALYTICAL REPORTING 
AND USAGE CALCULATIONS
Analyte levels of detection, levels of reporting, highest detection, excretion factors and 
standard doses from the literature.
Analyte
Level of 
detection 
(LOD) [ng/L]
Level of 
reporting 
(LOR) [ng/L]
Excretion 
Factor
Standard 
dose pure 
drug (mg)
Amphetamine 12 16 0.394a 30b
Cocaine 17 50 0.075b 100b
Cotinine 33 100 0.3c 1.25c
Norfentanyl 0.1 0.1 0.3d 0.2d
JWH-018 1 14 n.a. n.a.
JWH-073 10 20 n.a. n.a.
MDA * 1 4 n.a. n.a.#
MDMA 1.5 2 0.225b 100b
Mephedrone 0.4 0.8 n.a. n.a
Methylamphetamine 33 100 0.39g 30b
Methylone 0.01 0.1 n.a. n.a.
Hydroxycotinine 17 50 0.44c 1.25c
Noroxycodone 0.1 1 0.22f 20d
Ethyl sulphate 167 500 0.00012e 10ge
Benzoylecgonine 33 100 0.35g 100b
6-monoacetylmorphine 0.5 1.0 0.013h 20i
n.a. = data not available; a = (Khan and Nicell 2012) ; b = (Zuccato et al. 2008); c = (Castiglioni et al. 2015); 
d = (Rossi 2016), e = (Ryu et al. 2016); f = (Lalovic et al. 2006); g = (Lai et al., 2011); h = (Boerner et al., 1975);  
i =(Sullivan et al. 2006)
* Data is not available in the scientific literature for the proportion of MDA that is eliminated after MDA 
consumption. However, data is available detailing the proportion of MDA eliminated after MDMA consumption. 
Therefore, our MDA estimate of mg excreted per day per 1 000 people is the amount of MDA excreted from the 
population after considering the metabolic fraction excreted from MDMA.
# It is likely that the dose for MDA is similar to that of MDMA, of 100 mg.
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APPENDIX 4: POPULATION ESTIMATION: PERCENTAGE OVERCOUNT OR 
UNDERCOUNT BY SITE
Percentage undercount, overcount and total overcount or undercount for all site 
population estimates.
Site 
number
State Capital or 
regional
Potential 
undercount (%)
Potential 
overcount (%)
Total undercount 
+ overcount (%)
001 VIC Capital 2.11 1.97 4.08
002 QLD Capital 1.03 1.23 2.26
003 NSW Capital 0.61 0.57 1.18
004 TAS Capital 3.15 1.79 4.94
005 QLD Capital 1.17 1.12 2.29
006 NSW Capital 1.00 1.21 2.21
007 SA Capital 0.92 0.81 1.73
008 NSW Capital 1.71 1.90 3.61
009 ACT Capital 0.01 0.09 0.10
010 NT Capital 0.99 0.23 1.22
011 QLD Capital 2.28 2.72 5.00
012 QLD Regional 0.38 0.09 0.47
013 SA Capital 0.86 1.38 2.24
016 NSW Regional 1.91 1.75 3.66
017 SA Regional 2.65 0.69 3.34
018 TAS Regional 2.64 4.42 7.06
019 TAS Capital 0.74 0.44 1.18
020 QLD Regional 5.88 5.07 10.95
021 NSW Capital 2.32 2.55 4.87
022 SA Regional 2.67 2.17 4.84
024 QLD Regional 0.89 0.69 1.58
025 NSW Regional 1.52 1.29 2.81
027 SA Capital 4.45 5.05 9.50
028 QLD Regional 0.82 1.10 1.92
029 QLD Regional 0.59 0.99 1.58
033 QLD Regional 1.96 1.76 3.72
037 VIC Regional 0.80 0.92 1.72
038 TAS Regional 1.86 2.46 4.32
039 QLD Regional 0.07 0.29 0.36
040 NSW Regional 1.07 1.00 2.07
041 TAS Capital 1.31 2.41 3.72
046 VIC Regional 3.21 2.58 5.79
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Site 
number
State Capital or 
regional
Potential 
undercount (%)
Potential 
overcount (%)
Total undercount 
+ overcount (%)
048 TAS Regional 1.77 0.63 2.40
051 NSW Regional 0.41 0.14 0.55
053 QLD Regional 2.30 1.77 4.07
058 TAS Regional 2.74 1.63 4.37
059 SA Capital 0.69 0.67 1.36
061 VIC Regional 2.06 2.79 4.85
062 VIC Regional 7.25 6.94 14.19
063 SA Regional 0.87 0.44 1.31
066 VIC Regional 0.54 0.59 1.13
067 VIC Capital 0.99 0.96 1.95
068 NSW Regional 0.10 0.09 0.19
071 NSW Capital 0.22 0.22 0.44
076 SA Regional 2.86 3.07 5.93
077 QLD Regional 8.50 5.28 13.78
078 NT Regional 1.08 2.41 3.49
081 NSW Regional 0.37 1.59 1.96
085 NT Capital 0.23 0.86 1.09
101 WA Capital 0.71 0.74 1.45
102 WA Regional 1.35 0.19 1.54
103 WA Capital 1.13 1.03 2.16
104 WA Capital 0.27 0.23 0.50
114 VIC Regional 3.12 2.31 5.43
115 NSW Regional 2.52 3.13 5.65
118 WA Regional
No catchment 
map available
No catchment 
map available
No catchment 
map available
119 SA Regional 0.44 1.59 2.03
120 WA Regional
No catchment 
map available
No catchment 
map available
No catchment 
map available
129 WA Regional 17.49 0.82 18.31
Average (%): 1.99 1.63 3.62
Percentage undercount, overcount and total overcount or undercount for all site 
population estimates (continued).
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APPENDIX 5: POPULATION ESTIMATION METHODOLOGY:  
PERCENTAGE OVERCOUNT OR UNDERCOUNT BY SITE
The refined catchment population estimate uses the area of a mesh block within the 
catchment to estimate the proportion of the population within the catchment (where a mesh 
block is the smallest population unit of the 2016 Australian Census). However, when the 
population within the mesh blocks are not distributed equally this can decrease the precision 
of the estimate. The potential overcount and undercount estimates are a measure of precision 
of the refined population estimate. Some uncertainty is caused by the potential unequal 
population distribution for the mesh blocks that intersect the catchment boundary. A diagram 
outlining these terms is shown in the below figure, as well as the formulas used to calculate 
the overcount and undercount estimates. As can be seen in the figure, the population 
distribution across this particular mesh block is unequal when comparing the green and yellow 
areas. On average, the wastewater catchments used in this study had a 4 per cent combined 
population overcount or undercount estimate. This demonstrates that, in the vast majority 
of cases, the associated precision can be assumed to be very high for the Census-generated 
population estimates for the usual residence population. It should be noted that day-to-day 
population differences within a catchment due to seasonal tourism or commuting cannot be 
elucidated by this population estimate. However, for the capital city areas commuting is less 
likely to affect population estimates as multiple catchments per city are assessed concurrently 
(and include the CBD), so movement from one catchment to another would be captured. 
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Percentage overcount and undercount estimates surrounding the mesh block (Census) 
population estimate and the formulas used to calculate the overcount and undercount 
estimates. Note: the boundaries displayed are for instructional purposes only and do not 
relate to a real catchment.
x 100
Mesh block populations within boundary + mesh block populations outside boundary
Mesh block populations within boundary
Percent 
Undercount  = 
x 100Percent Undercount
Mesh block populations within boundary 
Mesh block populations with area fully within boundary (excluding yellow)
 = 
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CONCLUSIONS
For the fourth report of the National Wastewater Drug Monitoring Program, 
wastewater analysis was conducted in October and December 2017. The program has 
identified variations in patterns of drug consumption, both over time and within and 
between jurisdictions. Consistent with previous reports, findings show that, of the 
substances monitored, nicotine and alcohol are the most consumed drugs in Australia. 
Methylamphetamine remains the most consumed illicit drug of those tested in Australia, 
with estimated consumption significantly exceeding that of other monitored illicit drugs.
METHYLAMPHETAMINE
The population-weighted average consumption of methylamphetamine for both 
capital city and regional sites increased from August 2017 to December 2017. The 
regional average consumption of methylamphetamine exceeded capital city average 
consumption. South Australia had the highest estimated average capital city consumption 
of methylamphetamine in December 2017, with Western Australia having the highest 
estimated average regional consumption.
AMPHETAMINE
Amphetamine is a metabolite of methylamphetamine consumption. While the program 
measured amphetamine consumption, measured consumption was not reported separately 
as levels measured were consistent with observed levels related to methylamphetamine 
consumption.
COCAINE
The population-weighted average consumption of cocaine for both capital city and regional 
sites increased from August 2017 to December 2017. The capital city average consumption 
of cocaine was almost double the regional average. New South Wales had the highest 
estimated average capital city and regional consumption of cocaine in December 2017.
3,4-METHYLENEDIOXYMETHYLAMPHETAMINE (MDMA)
The population-weighted average consumption of MDMA in capital city sites remained 
relatively stable in December 2017, while there was an increase in regional sites compared 
to August 2017. Regional average consumption was very similar to capital city average 
consumption. The Northern Territory had the highest estimated average capital city 
consumption of MDMA in December 2017, with New South Wales and Queensland having 
the highest estimated average regional consumption.
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3,4-METHYLENEDIOXYAMPHETAMINE (MDA)
MDA is a metabolite of MDMA. As the proportion of MDA derived from MDMA is known, 
it has been possible from Report 3 to estimate MDA consumption rather that its presence 
solely as a metabolite of MDMA use. Regional average consumption of MDA exceeded 
capital city average consumption. Site 12 in Queensland is of particular concern given 
the very high consumption levels reported in December 2017. Tasmania had the highest 
estimated average capital city consumption of MDA in December 2017, with New South 
Wales and Queensland having the highest estimated average regional consumption.
HEROIN
Population-weighted averages for heroin consumption for both capital city and regional 
sites decreased from August 2017 to December 2017. Capital city average consumption of 
heroin is more than double regional average consumption. The Australian Capital Territory 
and Victoria had the highest estimated average capital city consumption of heroin in 
December 2017, with New South Wales having the highest estimated average regional 
consumption.
MEPHEDRONE
Consistent with previous reporting periods, mephedrone was mostly detected below the 
level at which it could be reliably quantified. The number of detections of mephedrone 
more than doubled between August and December 2017. Mephedrone was detected  
23 times at six sites in December 2017, compared to 11 times at seven sites in August 2017. 
In December 2017, mephedrone was detected in New South Wales and Queensland, with 
detections in August 2017 located in Queensland, Victoria and Western Australia.
METHYLONE
Consistent with previous reporting periods, methylone was mostly detected below the level 
at which it could be reliably quantified. The number of national detections of methylone 
decreased from 90 in August 2017 to 65 in December 2017. Methylone was detected at  
17 sites in December 2017, a decrease from the 22 sites in August 2017. In December 2017, 
methylone was detected in all states and territories with the exception of Western Australia, 
with detections of methylone in August 2017 located in all states and territories with the 
exception of the Australian Capital Territory and South Australia.
OXYCODONE
The population-weighted average consumption of oxycodone in regional sites remained 
relatively stable in December 2017 compared to August 2017, with an increase in capital city 
consumption. Regional average consumption of oxycodone was almost double the capital city 
average. Tasmania had the highest estimated average capital city consumption of oxycodone 
in December 2017, with Victoria having the highest estimated average regional consumption.
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FENTANYL
The population-weighted average consumption of fentanyl remained relatively stable in 
both capital city and regional sites in December 2017 compared to August 2017. Regional 
average consumption of fentanyl was almost double the capital city average. Tasmania had 
the highest estimated average capital city consumption of fentanyl in December 2017, with 
Queensland having the highest estimated average regional consumption.
NICOTINE1
Nicotine remains one of the most consumed drugs in Australia. The population-weighted 
average consumption of nicotine decreased between August 2017 and December 2017. 
The regional average consumption of nicotine exceeded capital city average consumption. 
The Northern Territory and Tasmania had the highest estimated average capital city 
consumption of nicotine in December 2017, with Tasmania having the highest estimated 
average regional consumption.
ALCOHOL
Alcohol remains one of the most consumed drugs in Australia. The population-weighted 
average alcohol consumption in both capital city and regional sites increased between 
August 2017 and December 2017. No significant differences in alcohol consumption were 
observed between capital city sites and regional sites. The Northern Territory had the highest 
estimated average capital city consumption of alcohol in December 2017, with Tasmania 
having the highest estimated average regional consumption.
NEXT REPORT
The fifth report of the National Wastewater Drug Monitoring Program is scheduled to be 
publicly released in the third quarter of 2018. The next report will incorporate the latest 
Sewage Analysis CORe group Europe (SCORE) data to provide insight into Australia’s drug 
consumption in comparison with that of other countries participating in the SCORE program.
1 For accuracy, estimates have been changed from tobacco in Report 1 and 2 to nicotine in this report due to the inability 
to distinguish between nicotine intake from tobacco or electric cigarettes and nicotine replacement therapies such as 
patches and gum.
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